Press release
Future Perspective: Key Trends Shaping the Infectious Disease Therapeutics Market Up to 2030
Infectious Disease Therapeutics Market
Projected Market Size and Growth of the Infectious Disease Therapeutics Market
The infectious disease therapeutics market is expected to experience robust growth, reaching a valuation of $200.87 billion by 2030. This growth corresponds to a compound annual growth rate (CAGR) of 5.7% throughout the forecast period. Contributing factors include increasing antimicrobial resistance, more frequent infectious disease outbreaks, broader vaccination coverage worldwide, escalating demand for innovative antiviral medications, and enhanced public health preparedness efforts. Key market trends anticipated in the coming years involve focused management of antimicrobial resistance, advances in broad-spectrum therapeutics, growing use of combination drug therapies, development of rapid-response treatments for outbreaks, and rising investments in vaccine research and stockpiling.
Download a free report of the infectious disease therapeutics market report:
https://www.thebusinessresearchcompany.com/report/infectious-disease-therapeutics-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Top Companies Leading the Infectious Disease Therapeutics Market
Several prominent pharmaceutical and biotechnology companies dominate the infectious disease therapeutics market landscape. These industry leaders include Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi SA, AstraZeneca, Novartis International AG, GlaxoSmithKline plc, Gilead Sciences Inc., Janssen Pharmaceuticals, Moderna Inc., Regeneron Pharmaceuticals Inc., Boehringer Ingelheim GmbH, and BioCryst Pharmaceuticals Inc.
Strategic Acquisitions Enhancing Market Position
In June 2023, Shionogi & Co., Ltd., a Japan-based pharmaceutical firm, expanded its infectious disease portfolio through the acquisition of Qpex Biopharma Inc., a US-based clinical-stage biotech company. This acquisition includes Qpex's advanced drug pipeline, highlighted by xeruborbactam, a first-of-its-kind ?-lactamase inhibitor targeting multidrug-resistant bacterial infections. Shionogi aims to leverage these novel antimicrobial treatments to strengthen its position in addressing serious and drug-resistant infectious diseases.
View the full infectious disease therapeutics market report:
https://www.thebusinessresearchcompany.com/report/infectious-disease-therapeutics-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Driving Factors Behind Growth in Infectious Disease Therapeutics
Rising levels of antimicrobial resistance are compelling healare providers and pharmaceutical companies to seek more effective and innovative treatment options. This challenge is escalating the need for new therapeutics capable of overcoming resistant pathogens, thereby fueling market expansion.
Additionally, the increasing frequency of infectious disease outbreaks worldwide demands rapid and effective therapeutic responses. Enhanced vaccination coverage and stronger public health initiatives also contribute to the growing market demand, collectively supporting sustained growth in this sector.
Key Trends Supporting Infectious Disease Therapeutics Advancement
The market is witnessing a shift toward broad-spectrum therapeutics that can target multiple pathogens simultaneously, streamlining treatment protocols and improving outcomes. Furthermore, combination drug therapies are gaining traction due to their potential to enhance efficacy and reduce the risk of resistance development.
Rapid-response therapeutics designed to address emerging infectious threats swiftly are becoming a critical focus area. Along with this, investment in vaccine research and strategic stockpiling is increasing to prepare for future outbreaks more effectively.
How the Infectious Disease Therapeutics Market Is Segmented
This market is organized into several segments to capture its diversity:
1) By Type:
- Drugs
- Vaccines
2) By Disease Category:
- Tuberculosis
- HIV/AIDS
- Influenza
- Hepatitis
- Other Diseases
3) By End-User:
- Hospitals and Clinics
- Retail Pharmacies
- Research Organizations
- Other End Users
Further subsegments include:
- Drugs: Antibiotics, Antivirals, Antifungals, Antiparasitics, Other Therapeutic Drugs such as Monoclonal Antibodies and Immunomodulators
- Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, Subunit Vaccines, mRNA Vaccines, DNA Vaccines, and Toxoid Vaccines
This detailed segmentation helps stakeholders understand where opportunities lie and how various therapies and end-user demands shape the market's future trajectory.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Future Perspective: Key Trends Shaping the Infectious Disease Therapeutics Market Up to 2030 here
News-ID: 4481253 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Artery Stenosis Drug Market
The artery stenosis drug market is on track for significant expansion as medical advancements and preventive care gain momentum. This sector is increasingly focused on enhancing patient outcomes through innovative therapies and improved management strategies for vascular diseases. Let's explore the current market size, key players, emerging trends, and segment breakdowns shaping the future of artery stenosis treatments.
Projected Growth and Market Size of the Artery Stenosis Drug Market
The…
Leading Companies Fueling Growth and Innovation in the Stroke Management Market
The stroke management sector is poised for notable advancement in the coming years, driven by significant technological progress and increasing healare investments. With a focus on enhancing diagnosis, treatment, and rehabilitation, this market is set to experience steady expansion and innovation. Let's explore the current market size, leading companies, key trends, and segment insights shaping the future of stroke management.
Projected Market Size and Growth Trajectory of the Stroke Management Market…
Trends in Growth, Segment Analysis, and Competitive Strategies Influencing the A …
The antivirals market is set for impressive growth over the coming years, driven by evolving healthcare demands and ongoing innovation. As viral infections continue to pose global health challenges, advancements in antiviral therapies and increased investment in research are shaping a promising future for this sector. Let's explore the market's expected growth, key players, emerging trends, and major segments that define its trajectory.
Antivirals Market Size and Projected Expansion by 2030…
Global Factors Influencing the Rapid Evolution of the Stool Softener Market
The stool softener market is positioned for significant expansion over the coming years, driven by various demographic and healare trends. As digestive health awareness rises and demand for gentle laxatives grows, this sector is expected to witness consistent growth, supported by advancements in product innovation and broader distribution networks.
Projected Market Size and Growth Rate of the Stool Softener Market
The stool softener market is anticipated to reach a valuation…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
